Biogenerics at the crossroads

被引：12

作者：

Ben-Maimon, CS ^{[1
]}

Garnick, R ^{[1
]}

机构：

[1] Barr Pharmaceut, Woodcliff Lake, NJ 07677 USA

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 03期

关键词：

D O I：

10.1038/nbt0306-268a

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Two executives-one from a leading generics manufacturer, the other from a leading brand manufacturer-argue the pros and cons of implementing an abbreviated US regulatory framework for the approval of biogeneric products.

引用

页码：268 / 269

页数：2

共 50 条

[41] Guides and medicine based on generics and biogenerics?
Gurfinkel, Enrique P.
[J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2011, 40 (01): : 3 - 4
[42] Pharma swept up in biogenerics gold rush
Ratner, Mark
[J]. NATURE BIOTECHNOLOGY, 2009, 27 (04) : 299 - 301
[43] RHEIN-BIOTECH PLANS TO PRODUCE BIOGENERICS
WARD, M
[J]. BIO-TECHNOLOGY, 1995, 13 (06): : 535 - 536
[44] 'Biogenerics': the off-patent biotech products
Schellekens, H
Ryff, JC
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (03) : 119 - 121
[45] Biogenerics: Are we ready to take safety challenges in India?
Budhiraja, Salil
Akinapel, Raghuram
[J]. INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (03) : 362 - U6
[46] BMGT 18 - Biogenerics: Their prospects for approval in the United States
Adler, Haskell T.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238 : 925 - 925
[47] Transplantation at the Crossroads: "The Crossroads Defined"
Freeman, Richard B.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 53 - 53
[48] America at the crossroads ('America at the Crossroads')
Fukuyama, F
[J]. NEW YORK TIMES BOOK REVIEW, 2006, : 6 - 6
[49] Europe at a crossroads Europe ata crossroads Europe at a crossroads Europe
Cook, N
[J]. AEROSPACE AMERICA, 1998, 36 (10) : E8 - E8
[50] Box 1 EMEA to release preclinical and clinical data requirements for biogenerics
Louët, S
[J]. NATURE BIOTECHNOLOGY, 2003, 21 (07) : 722 - 722

← 1 2 3 4 5 →